NCT06983028View on ClinicalTrials.gov

Atacicept in Multiple Glomerular Diseases

PHASE2RecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

July 7, 2025

Primary Completion Date

November 30, 2027

Study Completion Date

November 30, 2027

Conditions
pMNIgANNephrotic SyndromeMCDFSGS
Interventions
DRUG

Atacicept

Atacicept 150 mg SC QW via pre-filled syringe

Trial Locations (1)

94005

RECRUITING

Vera Therapeutics, Brisbane

All Listed Sponsors
lead

Vera Therapeutics, Inc.

INDUSTRY

NCT06983028 - Atacicept in Multiple Glomerular Diseases | Biotech Hunter | Biotech Hunter